Trial Profile
A multicentric phase II-III randomized study safety of intravenous liposomal pegylated doxorubicin versus continuous infusion of doxorubicin during induction treatment of acute lymphoblastic leukemia in patients
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Mercaptopurine; Methotrexate; Tioguanine; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 01 Mar 2008 New trial record.